DIABETIC RETINOPATHY: THE ROLE OF LIPOPROTEIN(A)

DIABETIC RETINOPATHY: THE ROLE OF LIPOPROTEIN(A) - DR & Lp(a)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON46153

Enrollment

Registered

2018-10-22

Start date

2018-12-06

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic retinopathy

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Age >= 18 years Informed consent Diabetic retinopathy

Exclusion criteria

Exclusion criteria: Other retinal pathology Glaucoma

Design outcomes

Primary

Measure	Time frame
Lp(a) concentration.	—

Secondary

Measure	Time frame
Molecular characteristics Lp(a).	—

Countries

Netherlands

Outcome results